Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jennifer Leigh Crombie, M.D.

Concepts (183)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymphoma, Large B-Cell, Diffuse12202414282.840 Why?
Lymphoma, B-Cell320249451.450 Why?
Immunotherapy, Adoptive8202415081.300 Why?
Leukemia, Lymphocytic, Chronic, B-Cell7202416431.200 Why?
Antibodies, Bispecific220242040.910 Why?
Hodgkin Disease5202213860.750 Why?
Burkitt Lymphoma120213370.610 Why?
Leukemia-Lymphoma, Adult T-Cell120191670.610 Why?
Antineoplastic Combined Chemotherapy Protocols102024118540.590 Why?
Genes, Immunoglobulin Heavy Chain12017580.570 Why?
Gene Expression Profiling4202195100.540 Why?
Hypercalcemia120194230.530 Why?
Pharmacogenetics120206830.500 Why?
Lymphoproliferative Disorders120195290.490 Why?
Sulfonamides3202219800.480 Why?
Cord Blood Stem Cell Transplantation120163050.450 Why?
Molecular Targeted Therapy3202028300.440 Why?
Loose Anagen Hair Syndrome1201210.420 Why?
Epidermolysis Bullosa Simplex12012120.420 Why?
Antineoplastic Agents52023136970.400 Why?
Proto-Oncogene Proteins c-bcl-22202414090.390 Why?
Antigens, CD19320234370.370 Why?
Vidarabine220243370.350 Why?
Tumor Lysis Syndrome22021380.330 Why?
Hematopoietic Stem Cell Transplantation7202357130.330 Why?
Neoplasm Recurrence, Local6202494330.330 Why?
Lymphoma, Mantle-Cell220232380.320 Why?
Lymph Nodes2202134710.310 Why?
Lymphoma, Follicular220234600.310 Why?
Lymphoma3202319070.300 Why?
Mutation52021302280.280 Why?
Medication Adherence1201821890.270 Why?
Receptors, Antigen, T-Cell3202325680.230 Why?
Neoplasm, Residual4202310190.230 Why?
Lymphoma, T-Cell220183030.230 Why?
Antigens, CD20220221990.220 Why?
Prognosis62023300220.220 Why?
Humans4320247683930.210 Why?
Lymphoma, Non-Hodgkin2202213760.210 Why?
Patient Readmission1201633120.200 Why?
Cyclophosphamide4202422260.200 Why?
Transplantation, Autologous6202321270.190 Why?
Adenine220249930.180 Why?
Therapies, Investigational120211110.170 Why?
Salvage Therapy2202412770.170 Why?
Endemic Diseases120211900.170 Why?
HTLV-I Antibodies12019350.170 Why?
Genes, myc120213910.170 Why?
Lethargy12019430.160 Why?
Neurotoxicity Syndromes120233020.160 Why?
Isotonic Solutions120191200.160 Why?
Calcitonin120193290.150 Why?
Africa South of the Sahara120217510.150 Why?
Piperidines2202416590.150 Why?
Central Nervous System2202313460.140 Why?
Clinical Trials, Phase I as Topic120183300.140 Why?
Nausea120196820.130 Why?
Vomiting120196550.130 Why?
Multigene Family1201910820.130 Why?
Benzamides1202113800.130 Why?
Pyrazines1202112060.130 Why?
Genetic Heterogeneity120197370.130 Why?
Herpesvirus 4, Human1202110820.120 Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 6120141210.120 Why?
Epstein-Barr Virus Infections120216170.120 Why?
Immunoconjugates120229690.120 Why?
Arsenicals120141170.120 Why?
Phosphatidylinositol 3-Kinases1202428840.110 Why?
Consensus1202432120.110 Why?
Europe1202134390.110 Why?
Socioeconomic Factors2201878610.110 Why?
Lymphocyte Activation1202454960.110 Why?
Keratin-1412012570.100 Why?
Benzylidene Compounds12012250.100 Why?
Neoplasms12021223850.100 Why?
Combined Modality Therapy1202485620.100 Why?
Adult1020242236400.100 Why?
Biological Products120219340.100 Why?
Glutathione120145850.100 Why?
Interviews as Topic1201927400.100 Why?
Neutropenia120178930.100 Why?
Central Nervous System Neoplasms120199300.090 Why?
Antibodies, Monoclonal3202392610.090 Why?
Nicotinic Agonists120122660.090 Why?
Retrospective Studies82024818010.090 Why?
Young Adult42024600490.090 Why?
Antigens, CD1202140310.090 Why?
Disease Management1202125370.090 Why?
Mitogen-Activated Protein Kinases1201412460.080 Why?
Middle Aged1120242234910.080 Why?
Drug Resistance, Neoplasm1202453360.080 Why?
Receptors, Nicotinic120124940.080 Why?
Fever1201616200.080 Why?
DNA Mutational Analysis1201741200.080 Why?
Neoplasm Proteins1202136100.080 Why?
Pyrazoles1201920210.080 Why?
T-Lymphocytes32023102670.080 Why?
Male1320243649020.070 Why?
Treatment Outcome62024653790.070 Why?
B-Lymphocytes1202147850.070 Why?
Positron-Emission Tomography1202366700.070 Why?
Aged920241715620.070 Why?
Aged, 80 and over32024596860.070 Why?
Pyrimidines1201930480.070 Why?
High-Throughput Nucleotide Sequencing1201936660.070 Why?
RNA, Messenger12021128050.070 Why?
Proto-Oncogene Proteins1201845260.070 Why?
Immunotherapy2202347380.060 Why?
Peptide Fragments1201851510.060 Why?
Leukocytes, Mononuclear2202318550.060 Why?
Genetic Testing1201935870.060 Why?
Female1120243970890.060 Why?
Lipopolysaccharides1201222150.060 Why?
Recurrence1201785060.060 Why?
Remission Induction2202124070.060 Why?
Stem Cell Transplantation2202316020.060 Why?
Clinical Trials as Topic1202080510.060 Why?
Genomics1202059160.060 Why?
Apoptosis2202495160.060 Why?
Diagnosis, Differential12019130200.060 Why?
Graft vs Host Disease1201630440.060 Why?
Survival Analysis12016101170.060 Why?
Randomized Controlled Trials as Topic12020103770.050 Why?
Gene Expression Regulation, Neoplastic1201986340.050 Why?
Child, Preschool22018426500.050 Why?
Protein Kinase Inhibitors1201957080.050 Why?
Switzerland120233230.050 Why?
Drug Administration Schedule2202148590.050 Why?
Age Factors12018184710.050 Why?
Burns1201218930.040 Why?
Pyridines1201228890.040 Why?
Disease-Free Survival2202268560.040 Why?
Time Factors22021402720.040 Why?
Macrocyclic Compounds12018670.040 Why?
Xenograft Model Antitumor Assays2201836170.040 Why?
Congresses as Topic120238100.040 Why?
Incidence12016215440.040 Why?
Cytarabine120206970.040 Why?
Comorbidity12012105880.040 Why?
Child22018808910.040 Why?
Macrophages1201257960.040 Why?
Immunoglobulin Heavy Chains120196480.030 Why?
Vincristine1201810400.030 Why?
Prospective Studies12020549200.030 Why?
Hematologic Diseases120194990.030 Why?
Mice, Inbred NOD1201818390.030 Why?
Prednisone1201815670.030 Why?
Lymphocytes1202126110.030 Why?
Intracellular Space120141990.030 Why?
Adolescent22019891840.030 Why?
Mice, SCID1201826320.030 Why?
Cell Line, Tumor22024171350.030 Why?
Bungarotoxins12012470.030 Why?
United States12021731500.030 Why?
Extracellular Signal-Regulated MAP Kinases120146150.020 Why?
Doxorubicin1201822290.020 Why?
Antibodies, Viral1202332110.020 Why?
Administration, Oral1201940390.020 Why?
Arsenic120143620.020 Why?
Tumor Cells, Cultured1201861320.020 Why?
Immunoglobulin G1202345700.020 Why?
Mice42024820170.020 Why?
Tumor Microenvironment1202339390.020 Why?
Risk Factors12016749620.020 Why?
Cell Death1201416820.020 Why?
Tumor Suppressor Protein p531201929520.020 Why?
Tumor Burden1201419130.020 Why?
Boston1202193710.020 Why?
CD8-Positive T-Lymphocytes1202146460.020 Why?
Survival Rate12022128700.020 Why?
Cell Cycle1201429380.020 Why?
Patient Selection1201842660.020 Why?
Animals420241693370.020 Why?
Cell Survival1201457920.010 Why?
Disease Models, Animal22014183620.010 Why?
Analysis of Variance1201262410.010 Why?
RNA, Small Interfering1201234340.010 Why?
Follow-Up Studies12024394070.010 Why?
Tumor Necrosis Factor-alpha1201243570.010 Why?
Cells, Cultured12012190220.010 Why?
Cell Proliferation12012104780.010 Why?
Mice, Inbred C57BL12012223550.010 Why?
Signal Transduction12014236310.010 Why?
Crombie's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (183)
Explore
_
Co-Authors (63)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.